BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27706622)

  • 21. XPG gene polymorphisms and cancer susceptibility: evidence from 47 studies.
    Huang J; Liu X; Tang LL; Long JT; Zhu J; Hua RX; Li J
    Oncotarget; 2017 Jun; 8(23):37263-37277. PubMed ID: 28416771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population.
    Ying MF; Zhao R
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations.
    He J; Qiu LX; Wang MY; Hua RX; Zhang RX; Yu HP; Wang YN; Sun MH; Zhou XY; Yang YJ; Wang JC; Jin L; Wei QY; Li J
    Hum Genet; 2012 Jul; 131(7):1235-44. PubMed ID: 22371296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
    He C; Duan Z; Li P; Xu Q; Yuan Y
    Anticancer Drugs; 2013 Mar; 24(3):300-5. PubMed ID: 23211354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XPG Gene Polymorphisms and the Risk of Gastric Cardia Adenocarcinoma.
    Zhou RM; Niu CX; Wang N; Liu L; Huang X; Chen ZF; Huo XR; Hao YL; Li Y
    Genet Test Mol Biomarkers; 2016 Aug; 20(8):432-7. PubMed ID: 27228234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population.
    He J; Wang F; Zhu J; Zhang R; Yang T; Zou Y; Xia H
    J Cell Mol Med; 2016 Aug; 20(8):1481-90. PubMed ID: 27019310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy.
    Chen J; Luo X; Xie G; Chen K; Jiang H; Pan F; Li J; Ruan Z; Pang X; Liang H
    Medicine (Baltimore); 2016 May; 95(19):e3652. PubMed ID: 27175691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between genetic variants in the
    Hua RX; Zhuo ZJ; Zhu J; Jiang DH; Xue WQ; Zhang SD; Zhang JB; Li XZ; Zhang PF; Jia WH; Shen GP; He J
    Aging (Albany NY); 2016 Dec; 8(12):3311-3320. PubMed ID: 27929383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population.
    Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
    Oncol Rep; 2021 Mar; 45(3):1295-1305. PubMed ID: 33469680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China.
    Hussain SK; Mu LN; Cai L; Chang SC; Park SL; Oh SS; Wang Y; Goldstein BY; Ding BG; Jiang Q; Rao J; You NC; Yu SZ; Papp JC; Zhao JK; Wang H; Zhang ZF
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2304-9. PubMed ID: 19661089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association Between XPG Gene Polymorphism and Gastric Cancer Risk.
    Su Y; Yang C; Zhang Z
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):619-624. PubMed ID: 28832189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the association between XRCC1 gene polymorphisms and susceptibility to gastric cancer.
    Chen S; Zhu XC; Liu YL; Wang C; Zhang KG
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on association between ERCC5 single nucleotide polymorphism and susceptibility to esophageal cancer.
    Zhang C; Liao Z; Yu G; Huang W; Song X
    J BUON; 2017; 22(4):979-984. PubMed ID: 28952217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations.
    Zhu ML; Shi TY; Hu HC; He J; Wang M; Jin L; Yang YJ; Wang JC; Sun MH; Chen H; Zhao KL; Zhang Z; Chen HQ; Xiang JQ; Wei QY
    PLoS One; 2012; 7(7):e41500. PubMed ID: 22848513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between polymorphisms of DNA repair gene ERCC5 and oral squamous cell carcinoma.
    Zavras AI; Yoon AJ; Chen MK; Lin CW; Yang SF
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):624-9. PubMed ID: 22981091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in prostate stem cell antigen gene rs2294008 increase gastric cancer risk in Chinese.
    Zeng Z; Wu X; Chen F; Yu J; Xue L; Hao Y; Wang Y; Chen M; Sung JJ; Hu P
    Mol Carcinog; 2011 May; 50(5):353-8. PubMed ID: 21268123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population.
    Sun Y; Tan L; Li H; Qin X; Liu J
    Int J Clin Exp Pathol; 2015; 8(9):11615-21. PubMed ID: 26617899
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Liu ZQ; Chen GG; Sun RL; Chen C; Lu MY; Guan LF; Chi XL; Jian YQ; Zhu X; Liu RQ; Cai BY; Chen FF; Liu B
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30139812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.